[ACRX] YoY Annual Result on 31-Dec-2014 [#FY]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
12-Mar-2015
Financial Year
2014
Quarter
31-Dec-2014 [#FY]
Profit Trend
YoY- -42.38%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Annual Result
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
Revenue 7,995 17,357 19,263 5,217 29,502 2,394 1,072 39.73%
PBT -52,209 -43,191 -23,639 -33,353 -23,426 -33,363 -20,101 17.22%
Tax -701 -34 760 6,935 -14,316 -1,367 749 -
NP -51,508 -43,157 -24,399 -33,353 -23,426 -33,363 -20,101 16.96%
Tax Rate - - - - - - - -
Total Cost 59,503 60,514 43,662 38,570 52,928 35,757 21,173 18.77%
Ratio Analysis
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
NP Margin -644.25 -248.64 -126.66 -639.31 -79.40 -1,393.61 -1,875.09 -16.29%
Per Share
31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 CAGR
EPS -21.97 -19.05 -11.02 -15.36 -11.79 -30.16 -23.18 -0.88%
EPS Diluted -21.97 -19.05 -10.97 -15.05 -11.79 -30.16 -23.18 -0.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.